Gluconeogenesis and Glycogen

Patient Case 1: Fatigue and Confusion

  • Patient Presentation: A 46-year-old woman experiencing fatigue and confusion after morning runs, accompanied by blurred vision. Symptoms are relieved by food consumption but are worsening, leading to increased food intake and weight gain.
  • Initial Recommendations:
    • Blood tests to check blood sugar levels.
    • Anticipation of low blood sugar levels in the patient.
  • Possible Underlying Reasons:
    • Insulin-related issues impacting blood sugar levels.
      • Could be inherited or presented.
      • Given the patient's age, a presented condition is more likely.
  • Hormone Testing:
    • Insulin and glucagon levels.
    • Findings: High insulin levels.
  • Insulin Function:
    • Tells the body to remove blood sugar from the blood and store it.
    • High insulin levels should not be present in the morning; glucagon levels should be higher.
    • Taking insulin without needing it can be dangerous, leading to reduced brain function due to low glucose levels.
  • Diagnosis Discussion:
    • Ruling out insulin resistance because insulin is still effective at lowering blood glucose.
    • Considering glucagon deficiency or resistance, but this doesn't fully explain the high insulin levels.
    • Exploring the possibility of issues with hormone production.
  • Final Diagnosis:
    • The patient has a tumor producing insulin, causing the observed symptoms.
    • Eating alleviates symptoms temporarily by increasing blood sugar, but the insulin produced by the tumor quickly removes it, perpetuating the cycle.

Patient Case 2: Liver Dysfunction and Muscle Weakness in a Child

  • Patient Presentation: A young child, normal at birth, develops liver dysfunction and muscle weakness at three months old.
    • Enlarged liver (hepatomegaly).
    • Periods of low blood sugar, especially upon waking.
    • Hyperlipidemia (elevated blood lipids).
    • Fasting ketoacidosis (ketone body production).
    • Elevated liver enzymes in the blood, indicating liver damage.
    • Liver biopsy reveals elevated glycogen content.
    • No debranching enzyme activity observed in liver and muscles.
  • Glycogen Metabolism:
    • Overnight, glycogen is normally converted into glucose.
    • The debranching enzyme is required to access glucose efficiently from glycogen.
    • Without the debranching enzyme, glycogen can only be trimmed to a certain point, limiting glucose release.
  • Liver Enlargement:
    • Due to glycogen buildup because it cannot be properly broken down.
    • Normally, glycogen stores in the liver are depleted by morning.
  • Impact of Carbohydrate-Rich Meals:
    • Worsens the condition by further enlarging the liver.
    • More frequent meals of glucose may be better to manage glycogen levels.
  • Ketone Bodies:
    • Produced as an alternative fuel source for the brain when glucose is limited.
  • Glucose Production:
    • The patient CAN produce glucose through gluconeogenesis, utilizing the glycerol moiety of fat.
  • Gluconeogenesis:
    • Important pathway for maintaining blood glucose levels, especially during prolonged fasting.
    • Uses non-carbohydrate components to produce glucose.
  • High-Fat, Ketogenic Diet:
    • May be a possible management strategy.

Patient Case 3: Elevated Glycerol Levels

  • Patient Presentation: Four-year-old boy hospitalized with fever, vomiting, and diarrhea, thought to be due to a viral infection.
    • Elevated glycerol levels (10 times normal) in blood and urine.
    • Reoccurring episodes over several weeks.
    • Occasional loss of consciousness due to low blood sugar levels.
  • Sources of Glycerol:
    • Triacylglycerol (fat).
    • The glycerol molecule attached to fatty acids.
  • Metabolic Intermediates:
    • Dihydroxyacetone phosphate (DAP) and glyceraldehyde-3-phosphate, intermediates in glycolysis, are structurally similar to glycerol.
    • Glycerol can feed back into gluconeogenesis through these intermediates to produce glucose.
  • Elevated Glycerol - Why?
    • Accumulation of a metabolite. Usually suggests enzyme issue.
    • Could be associated with high consumption of a fatty diet.
  • Enzyme Conversion:
    • Enzyme needed to convert glycerol into DAP.
    • If there's a mutation or dysfunction in an enzyme, that causes dysfunction.
  • Genetic Sequencing:
    • Sequence the patient's genome to identify the enzyme deficiency.
  • Inherited Condition:
    • Most likely inherited due to the early age of onset.
  • Impact on Gluconeogenesis:
    • The patient will have issues with gluconeogenesis because glycerol is not converted effectively.

Regulation of Gluconeogenesis

  • Key Regulatory Point: The conversion between fructose-6-phosphate and fructose-1,6-bisphosphate.
    • In glycolysis, fructose-6-phosphate converted to fructose-1,6-bisphosphate by phosphofructokinase-1 (PFK-1).
    • In gluconeogenesis, fructose-1,6-bisphosphate converted back to fructose-6-phosphate by fructose-1,6-bisphosphatase.
  • Fructose-2,6-bisphosphate:
    • A metabolite that controls flux through the pathway.
    • Promotes activity of PFK-1 (glycolysis) and inhibits fructose-1,6-bisphosphatase (gluconeogenesis).
    • Low levels favor gluconeogenesis; high levels favor glycolysis.
  • Production of Fructose-2,6-bisphosphate:
    • Produced by phosphofructokinase-2 (PFK-2), a bifunctional enzyme with both kinase and phosphatase domains.
    • PFK-2 can convert fructose-6-phosphate into fructose-2,6-bisphosphate and vice versa.
  • Regulation of PFK-2 Activity:
    • Controlled by phosphorylation.
    • When phosphorylated, the kinase domain is INactivated, reducing fructose-2,6-bisphosphate.
    • Phosphorylation favors gluconeogenesis.
  • Glucagon's Role:
    • Glucagon levels rise when blood sugar falls, stimulating gluconeogenesis.
    • Glucagon binds to its receptor in the liver, activating a protein that produces cyclic AMP (cAMP).
    • cAMP activates protein kinase A (PKA), which phosphorylates PFK-2, INactivating its kinase activity.
    • This reduces fructose-2,6-bisphosphate levels, favoring gluconeogenesis.
  • Without Glucagon Signaling:
    • PFK-2 is not phosphorylated.
    • Fructose-2,6-bisphosphate promotes glycolysis.
  • With Glucagon:
    • PFK-2 is phosphorylated, and is INACTIVE, meaning fructose-2,6-bisphosphate is not produced.
    • Fructose-2,6-bisphosphate levels decrease.
    • Gluconeogenesis is accelerated.
  • Acetyl CoA Regulation:
    • High levels of acetyl CoA (indicating plenty of energy) can inhibit glycolysis and indirectly promote gluconeogenesis.
  • Summary: Allosteric regulators (such as Acetyl CoA) don't need to be there, however help the enzyme work optimally.